Strategy, Governance and Guiding Principles



Today, many neurological diseases remain largely untreated. But at Biogen, we believe we are at the forefront of unlocking promising scientific breakthroughs that have the potential to impact the lives of patients around the globe.






We aim to further expand our multi-franchise portfolio to address the vast unmet need in neuroscience. We believe no other area of medicine holds as much promise for scientific breakthroughs that can impact the lives of patients.

Through our research, we increasingly see that many neurological disease areas and the therapeutic strategies that treat them are interconnected. With knowledge gained from one area resonating across our pipeline, we have identified a set of scientific hypotheses with the potential to uncover medical breakthroughs across our disease areas.






The Company’s Certificate of Incorporation and Bylaws, together with our corporate governance principles, provide the framework for the corporate governance of Biogen. The Board reviews these governing documents and principles, as well as other aspects of the Company’s governance, on a regular basis.





Guiding principles

Our commitment is grounded in our Code of Business Conduct (Values in Action), our Sustainability Policy and our other related policies and position statements. These principles and policies outline our focus on ethical business conduct, compliance, accountability and transparency, among other topics. To review the full list of our commitments, visit Our Guiding Principles.

The foundation of everything we do is built around evidence-based science – for our business, for patients and for the environment. Our climate reduction targets, as well as our broader commitment to environmental sustainability, are science-based.